Reports and Briefs on Pharmaceuticals

Published within

« | ... | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ... | » »|

Type Product title / description Pub Price
Report
Report

Actelion Ltd: PharmaVitae Report

Analysis of Actelion's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
20 Oct 2011 $2800
Buy
Report
Report

Gilead Sciences Inc.: PharmaVitae Report

Analysis of Gilead's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
20 Oct 2011 $2800
Buy
Report
Report

5EU: Pricing, Reimbursement and Regulatory Update

Datamonitor’s report 5EU: Pricing, Reimbursement, and Regulatory Update provides an overview of developments regarding healthcare reforms, drug regulation, and drug pricing and reimbursement in France, Germany, Italy, Spain, and the UK.

Published By Datamonitor
28 Oct 2011 $1520
Buy
Report
Report

Monoclonal Antibodies: 2011

Historical and forecast analysis of the monoclonal antibodies sector from 2004 through to 2016.

Published By Datamonitor
31 Oct 2011 $2800
Buy
Report
Report

Canada: Generics and Biosimilars Overview

Overview of the generics and biosimilars landscape including, regulatory issues, drivers and resistors to uptake, level of penetration, and key players operating in the market.

Published By Datamonitor
03 Nov 2011 $1520
Buy
Report
Report

US: Healthcare Reform, Intellectual Property and Regulatory Update

Datamonitor’s report provides an overview of developments regarding drug regulation, healthcare reform, and intellectual property issues in the US.

Published By Datamonitor
15 Nov 2011 $1520
Buy
Report
Report

Seattle Genetics, Inc.: PharmaVitae Report

This report analyzes Seattle Genetics' corporate strategy, sales outlook and financial position through to 2016, supported by in-depth analysis of the company’s key products, driven by patient-based forecasts and key opinion leader interviews.

Published By Datamonitor
17 Nov 2011 $2800
Buy
Report
Report

Japan: Pricing, Reimbursement and Regulatory Update

Datamonitor’s report Japan: Pricing, Reimbursement, and Regulatory Update provides an overview of developments regarding healthcare reforms, drug regulation, and drug pricing and reimbursement in Japan.

Published By Datamonitor
18 Nov 2011 $1520
Buy
Report
Report

CSL Limited: PharmaVitae Report

Analysis of CSL's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
18 Nov 2011 $2800
Buy
Report
Report

Big Pharma Company Outlook to 2016

Analysis of the outlook for Datamonitor's Big Pharma peer set of companies through to 2016, identifying key strategic themes and looking at sales performance by company, lifecycle stage, therapy area, and molecule type

Published By Datamonitor
18 Nov 2011 $2800
Buy

« | ... | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ... | » »|

No help is available.